Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Neurologists need to understand and be able to identify the most distinguishing features of permanent vegetative state. Virtual Mentor. 2004;6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411. Pagination First page « First Previous page ‹ Previous … Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Current page 18
State of the Art and Science Aug 2004 Diagnosing The Permanent Vegetative State Ronald Cranford, MD Neurologists need to understand and be able to identify the most distinguishing features of permanent vegetative state. Virtual Mentor. 2004;6(8):350-352. doi: 10.1001/virtualmentor.2004.6.8.cprl1-0408.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in. Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Medicine and Society Nov 2004 Gatekeeping and the FDA's Role in Human Subjects Protection Daniel Carpenter, PhD The FDA bears the responsibility to monitor clinical trials and protect human subjects from harm. Virtual Mentor. 2004;6(11):512-514. doi: 10.1001/virtualmentor.2004.6.11.msoc1-0411.